A YOUNG woman who developed stress-related alopecia has revealed how she went from being almost bald to having a bob in less ...
A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...
News-Medical.Net on MSN3d
Researchers develop new compound to treat alopecia areataA research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...
The researchers tested their new itaconate-based prodrugs in mice and found that at least two of them were highly effective. The treatment was well-absorbed, reduced inflammation, and stimulated hair ...
Researchers have developed a compound that could potentially treat the autoimmune disorder alopecia areata, which causes hair ...
In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways ...
and colleagues examined the efficacy and safety of ivarmacitinib in adults with severe AA (≥50% scalp hair loss, including alopecia totalis/universalis) in a phase 3 trial. Three hundred thirty ...
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 ...
Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback